MECASERMIN

MECASERMIN was reported 685 times

MECASERMIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TRIPLE A SYNDROME 1 0.5000
1 OSTEOFIBROMA 1 0.3333
2 INTESTINAL NEURONAL DYSPLASIA 1 0.3333
3 TESTICULAR APPENDAGE TORSION 1 0.2500
4 AURAL POLYP 5 0.1190
5 SECRETORY ADENOMA OF PITUITARY 1 0.0909
6 CAECUM OPERATION 1 0.0833
7 RADIOALLERGOSORBENT TEST POSITIVE 1 0.0769
8 LACTASE DEFICIENCY 1 0.0714
9 OVARIAN GRANULOSA CELL TUMOUR 2 0.0714
10 IMPLANT SITE PAPULES 1 0.0667
11 CARTILAGE HYPERTROPHY 1 0.0588
12 OVARIAN GRANULOSA-THECA CELL TUMOUR 2 0.0571
13 MULTIPLE ENDOCRINE NEOPLASIA 1 0.0526
14 EYEGLASSES THERAPY 1 0.0500
15 RATHKE'S CLEFT CYST 1 0.0500
16 CARTILAGE NEOPLASM 1 0.0476
17 PAEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDERS ASSOCIATED WITH STREPTOCOCCAL INFECTION 1 0.0476
18 BILATERAL BREAST BUDS 1 0.0455
19 ADENOIDAL HYPERTROPHY 12 0.0435
20 SPLENIC VARICES 1 0.0417
21 INFERIORITY COMPLEX 1 0.0333
22 STERNOTOMY 1 0.0333
23 ACTH STIMULATION TEST ABNORMAL 1 0.0323
24 INSULIN RESISTANCE SYNDROME 1 0.0303
25 TONSILLAR HYPERTROPHY 31 0.0287
26 MANUFACTURING PRODUCTION ISSUE 1 0.0250
27 DIABETES MELLITUS MANAGEMENT 1 0.0250
28 TESTICULAR TORSION 2 0.0244
29 AUTOSOMAL CHROMOSOME ANOMALY 1 0.0217
30 NASAL TURBINATE HYPERTROPHY 4 0.0213
31 DYSPLASTIC NAEVUS SYNDROME 1 0.0213
32 ECHINOCOCCIASIS 1 0.0208
33 ENCOPRESIS 3 0.0200
34 OPTIC DISCS BLURRED 1 0.0200
35 TYMPANIC MEMBRANE HYPERAEMIA 1 0.0185
36 CYSTIC LUNG DISEASE 1 0.0182
37 OESOPHAGOGASTRIC FUNDOPLASTY 2 0.0180
38 VOLVULUS OF SMALL BOWEL 2 0.0179
39 ADENOTONSILLECTOMY 3 0.0168
40 EPIPHYSIOLYSIS 3 0.0165
41 RETINOPATHY PROLIFERATIVE 2 0.0160
42 CSF WHITE BLOOD CELL COUNT POSITIVE 1 0.0149
43 KARYOTYPE ANALYSIS ABNORMAL 1 0.0139
44 LACK OF ADMINISTRATION SITE ROTATION 1 0.0133
45 EXCESSIVE EXERCISE 1 0.0132
46 OVARIAN TORSION 1 0.0120
47 HETEROPHORIA 1 0.0112
48 NEUTRALISING ANTIBODIES 1 0.0112
49 MALOCCLUSION 2 0.0108
50 BLOOD GROWTH HORMONE ABNORMAL 1 0.0108
51 ADENOMATOUS POLYPOSIS COLI 1 0.0108
52 GASTRITIS VIRAL 1 0.0106
53 CARDIAC VENTRICULAR DISORDER 3 0.0106
54 ACROMEGALY 2 0.0094
55 OTITIS MEDIA CHRONIC 3 0.0093
56 ANOREXIA NERVOSA 2 0.0091
57 BONE LESION EXCISION 1 0.0086
58 TONGUE BLACK HAIRY 1 0.0084
59 CONGENITAL NAEVUS 1 0.0083
60 BLOOD KETONE BODY PRESENT 1 0.0083
61 ACANTHOSIS NIGRICANS 1 0.0082
62 SIGHT DISABILITY 1 0.0077
63 PRECOCIOUS PUBERTY 3 0.0074
64 NOSE DEFORMITY 2 0.0073
65 ENLARGED CLITORIS 1 0.0072
66 BENIGN INTRACRANIAL HYPERTENSION 9 0.0072
67 HYPERSPLENISM 2 0.0071
68 OVARIAN ADENOMA 1 0.0071
69 CHEST WALL HAEMATOMA 1 0.0066
70 OSTEOCHONDROSIS 5 0.0066
71 SPIDER NAEVUS 1 0.0065
72 VISUAL ACUITY TESTS ABNORMAL 1 0.0064
73 DEVICE EXTRUSION 1 0.0063
74 VAGINAL ABSCESS 1 0.0061
75 ADNEXAL TORSION 1 0.0061
76 INJECTION SITE HYPERTROPHY 1 0.0060
77 ADENOIDAL DISORDER 1 0.0058
78 ABDOMINOPLASTY 1 0.0058
79 OVERGROWTH BACTERIAL 1 0.0056
80 GROWING PAINS 1 0.0056
81 BIRTH MARK 1 0.0056
82 LIGAMENT OPERATION 1 0.0054
83 EOSINOPHILIC OESOPHAGITIS 2 0.0054
84 LIMB TRAUMATIC AMPUTATION 1 0.0053
85 REFRACTION DISORDER 1 0.0053
86 URETERIC DILATATION 1 0.0051
87 GROWTH FAILURE 1 0.0051
88 DIET NONCOMPLIANCE 1 0.0050
89 APOPTOSIS 1 0.0048
90 BONE DEVELOPMENT ABNORMAL 1 0.0047
91 LIPOHYPERTROPHY 2 0.0046
92 CONDUCTIVE DEAFNESS 1 0.0045
93 CHRONIC MYELOMONOCYTIC LEUKAEMIA 2 0.0045
94 MUSCLE HYPERTROPHY 1 0.0044
95 ADENOIDECTOMY 1 0.0044
96 SNORING 11 0.0043
97 IDIOPATHIC INTRACRANIAL HYPERTENSION 5 0.0043
98 TYMPANIC MEMBRANE DISORDER 1 0.0043
99 TOXOPLASMOSIS 3 0.0042
100 DRUG ADMINISTERED IN WRONG DEVICE 2 0.0041
101 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0041
102 VULVAL ABSCESS 1 0.0040
103 ENTEROBACTER SEPSIS 1 0.0040
104 PAPILLOEDEMA 12 0.0039
105 GROWTH RETARDATION 8 0.0038
106 INSULIN-LIKE GROWTH FACTOR INCREASED 4 0.0038
107 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 3 0.0037
108 LYMPHOID TISSUE HYPERPLASIA 1 0.0037
109 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0036
110 SOFT TISSUE SWELLING 1 0.0035
111 COMPLICATIONS OF BONE MARROW TRANSPLANT 1 0.0035
112 LIMB ASYMMETRY 2 0.0034
113 OVARIAN ENLARGEMENT 1 0.0033
114 POLYCYSTIC OVARIES 3 0.0032
115 BLOOD INSULIN INCREASED 1 0.0030
116 INTRACRANIAL PRESSURE INCREASED 11 0.0030
117 OPEN FRACTURE 1 0.0029
118 IGA NEPHROPATHY 2 0.0028
119 LOW SET EARS 1 0.0027
120 BODY MASS INDEX INCREASED 2 0.0026
121 AMBLYOPIA 1 0.0026
122 ENDOMETRIAL ADENOCARCINOMA 1 0.0026
123 PROCEDURAL VOMITING 1 0.0026
124 HYPERTROPHY 1 0.0025
125 ESCHERICHIA TEST POSITIVE 2 0.0025
126 HYDROCELE 2 0.0024
127 OTITIS EXTERNA 2 0.0024
128 BUNION OPERATION 1 0.0024
129 FEBRILE CONVULSION 2 0.0024
130 INSULIN-LIKE GROWTH FACTOR DECREASED 1 0.0023
131 METAL POISONING 1 0.0022
132 HYPERTROPHIC CARDIOMYOPATHY 2 0.0021
133 MELANOCYTIC NAEVUS 6 0.0021
134 THYROXINE FREE INCREASED 1 0.0021
135 OTITIS MEDIA 5 0.0021
136 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1 0.0020
137 KETOSIS 1 0.0020
138 SICKLE CELL ANAEMIA 1 0.0019
139 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0018
140 TESTICULAR ATROPHY 1 0.0018
141 NASAL OEDEMA 2 0.0018
142 AXONAL NEUROPATHY 1 0.0017
143 SPINAL FUSION SURGERY 4 0.0017
144 CULTURE URINE POSITIVE 2 0.0017
145 FACIAL ASYMMETRY 1 0.0017
146 INJECTION RELATED REACTION 1 0.0017
147 BREATH ODOUR 3 0.0017
148 SPLENIC INFARCTION 2 0.0017
149 GINGIVAL HYPERPLASIA 1 0.0017
150 SELECTIVE EATING DISORDER 1 0.0016
151 ADENOMA BENIGN 1 0.0016
152 FIBROMA 1 0.0016
153 INJECTION SITE MACULE 1 0.0016
154 PHARYNGEAL HYPOAESTHESIA 1 0.0016
155 HYPERPLASIA 1 0.0015
156 HYPOGLYCAEMIA 54 0.0015
157 HYPERMETROPIA 1 0.0015
158 HEPATIC INFECTION 1 0.0015
159 MUSCLE SWELLING 1 0.0015
160 PYLORIC STENOSIS 1 0.0015
161 AORTIC DILATATION 1 0.0014
162 VOLVULUS 2 0.0014
163 ULNA FRACTURE 1 0.0014
164 T-CELL LYMPHOMA 1 0.0014
165 INJECTION SITE HYPERSENSITIVITY 2 0.0014
166 SKIN TEST POSITIVE 1 0.0014
167 DYSPLASIA 1 0.0014
168 HYPOGLYCAEMIC SEIZURE 1 0.0013
169 PNEUMONIA STREPTOCOCCAL 1 0.0013
170 RHINOVIRUS INFECTION 2 0.0013
171 INJECTION SITE URTICARIA 19 0.0013
172 GINGIVAL HYPERTROPHY 1 0.0013
173 CARDIAC HYPERTROPHY 1 0.0013
174 EPIDIDYMITIS 1 0.0013
175 PHARYNGEAL ERYTHEMA 2 0.0012
176 VITH NERVE PARALYSIS 1 0.0012
177 TONSILLAR DISORDER 1 0.0012
178 HYPOVITAMINOSIS 1 0.0012
179 ENDOCRINE DISORDER 1 0.0012
180 LIP ULCERATION 1 0.0012
181 LIP DISCOLOURATION 1 0.0012
182 RADIUS FRACTURE 2 0.0012
183 CEREBRAL VENTRICLE DILATATION 1 0.0012
184 PRODUCT SUPPLY ISSUE 2 0.0011
185 SOFT TISSUE DISORDER 1 0.0011
186 PHARYNGITIS STREPTOCOCCAL 7 0.0011
187 ADNEXA UTERI PAIN 1 0.0010
188 STRABISMUS 2 0.0010
189 SCOLIOSIS 4 0.0010
190 CALCULUS URINARY 1 0.0009
191 FACIAL PALSY 2 0.0009
192 RETINAL OEDEMA 1 0.0009
193 HAIR TEXTURE ABNORMAL 10 0.0009
194 PAPILLARY THYROID CANCER 1 0.0009
195 JAW DISORDER 4 0.0009
196 COMPLEX PARTIAL SEIZURES 1 0.0009
197 GAZE PALSY 1 0.0009
198 TONSILLECTOMY 1 0.0009
199 WEIGHT ABNORMAL 1 0.0009
200 PITUITARY TUMOUR BENIGN 1 0.0009
201 BONE MARROW TRANSPLANT 1 0.0008
202 OPTIC NERVE DISORDER 1 0.0008
203 LYMPH NODE PAIN 1 0.0008
204 BLOOD CHOLESTEROL DECREASED 1 0.0008
205 MASTITIS 1 0.0008
206 INSULIN RESISTANCE 1 0.0008
207 NASAL SEPTUM DEVIATION 1 0.0008
208 INDURATION 1 0.0008
209 NON-HODGKIN'S LYMPHOMA 1 0.0008
210 DRUG LEVEL BELOW THERAPEUTIC 2 0.0008
211 MITRAL VALVE DISEASE 1 0.0007
212 BLOOD GLUCOSE DECREASED 26 0.0007
213 HUNGER 5 0.0007
214 WEIGHT GAIN POOR 1 0.0007
215 SKIN INDURATION 1 0.0007
216 BACTERIAL TEST POSITIVE 1 0.0007
217 MIDDLE EAR EFFUSION 1 0.0007
218 SLEEP APNOEA SYNDROME 9 0.0007
219 CEREBRAL ATROPHY 2 0.0007
220 GOITRE 2 0.0007
221 GASTROINTESTINAL OBSTRUCTION 1 0.0007
222 SCREAMING 3 0.0006
223 EAR PRURITUS 1 0.0006
224 INCREASED APPETITE 7 0.0006
225 FEAR OF INJECTION 2 0.0006
226 INJECTION SITE INDURATION 6 0.0006
227 ANIMAL BITE 1 0.0006
228 EXPIRED DRUG ADMINISTERED 3 0.0006
229 RED BLOOD CELL COUNT INCREASED 1 0.0006
230 PRODUCT CONTAMINATION 1 0.0006
231 HYPOGLYCAEMIC UNCONSCIOUSNESS 1 0.0006
232 TONSILLITIS 2 0.0006
233 INJECTION SITE VESICLES 2 0.0006
234 VOMITING PROJECTILE 1 0.0006
235 NASAL DISORDER 1 0.0006
236 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0006
237 HORDEOLUM 1 0.0006
238 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0006
239 PERSONALITY DISORDER 1 0.0005
240 DYSMORPHISM 1 0.0005
241 SKIN HYPERTROPHY 1 0.0005
242 STARING 1 0.0005
243 CLONUS 1 0.0005
244 VITREOUS HAEMORRHAGE 1 0.0005
245 BRUXISM 2 0.0005
246 HEPATOSPLENOMEGALY 1 0.0005
247 OSTEITIS 1 0.0005
248 BLOOD SODIUM INCREASED 1 0.0005
249 CYSTIC FIBROSIS 2 0.0005
250 EYELID OEDEMA 5 0.0005
251 INJECTION SITE PRURITUS 23 0.0005
252 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0005
253 EPSTEIN-BARR VIRUS INFECTION 2 0.0005
254 NEPHRITIS 1 0.0005
255 LIVER ABSCESS 1 0.0005
256 THYROID MASS 1 0.0005
257 PORTAL HYPERTENSION 1 0.0005
258 DUODENITIS 1 0.0005
259 DEAFNESS NEUROSENSORY 1 0.0005
260 DRUG LEVEL ABOVE THERAPEUTIC 1 0.0005
261 DIABETIC COMPLICATION 1 0.0005
262 LUMBAR SPINAL STENOSIS 1 0.0005
263 URINE ANALYSIS ABNORMAL 1 0.0005
264 REGURGITATION 1 0.0004
265 VENTRICULAR HYPERTROPHY 1 0.0004
266 AUTOIMMUNE THYROIDITIS 1 0.0004
267 MALNUTRITION 3 0.0004
268 SPINAL COLUMN STENOSIS 2 0.0004
269 SOCIAL AVOIDANT BEHAVIOUR 2 0.0004
270 B-CELL LYMPHOMA 1 0.0004
271 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 1 0.0004
272 CLAVICLE FRACTURE 1 0.0004
273 TENSION HEADACHE 1 0.0004
274 EAR INFECTION 6 0.0004
275 EXCORIATION 1 0.0004
276 HEREDITARY ANGIOEDEMA 2 0.0004
277 BREAST ENLARGEMENT 1 0.0004
278 VIRAL INFECTION 8 0.0004
279 ABSCESS LIMB 1 0.0004
280 BLOOD GLUCOSE FLUCTUATION 3 0.0004
281 SPLENOMEGALY 3 0.0004
282 NEEDLE ISSUE 4 0.0004
283 GENERALISED OEDEMA 3 0.0004
284 INJECTION SITE MASS 8 0.0004
285 CRYING 10 0.0004
286 GASTROENTERITIS VIRAL 4 0.0004
287 GENERALISED ERYTHEMA 2 0.0003
288 HEPATIC CIRRHOSIS 4 0.0003
289 DISEASE COMPLICATION 1 0.0003
290 HYPERTHYROIDISM 3 0.0003
291 RETINAL DETACHMENT 2 0.0003
292 INJECTION SITE IRRITATION 3 0.0003
293 EXOSTOSIS 2 0.0003
294 BLEPHAROSPASM 1 0.0003
295 PROTEIN URINE PRESENT 1 0.0003
296 TEMPERATURE INTOLERANCE 2 0.0003
297 AORTIC VALVE INCOMPETENCE 1 0.0003
298 HYPERNATRAEMIA 1 0.0003
299 TEARFULNESS 1 0.0003
300 INCREASED TENDENCY TO BRUISE 2 0.0003
301 GASTROENTERITIS 3 0.0003
302 ENDOCARDITIS 1 0.0003
303 MYELODYSPLASTIC SYNDROME 3 0.0003
304 BACTERAEMIA 2 0.0003
305 PALLOR 5 0.0003
306 STREPTOCOCCAL INFECTION 1 0.0003
307 VIITH NERVE PARALYSIS 1 0.0003
308 MALABSORPTION 1 0.0003
309 FOOT DEFORMITY 2 0.0003
310 CACHEXIA 1 0.0003
311 PERIORBITAL OEDEMA 1 0.0003
312 INJECTION SITE SWELLING 13 0.0003
313 APPETITE DISORDER 1 0.0003
314 TYPE 1 DIABETES MELLITUS 1 0.0003
315 LIP SWELLING 6 0.0003
316 NASAL CONGESTION 9 0.0003
317 HYDROCEPHALUS 1 0.0003
318 VENTRICULAR TACHYCARDIA 3 0.0003
319 OSTEONECROSIS 6 0.0003
320 AUTOIMMUNE DISORDER 1 0.0003
321 INJECTION SITE ERYTHEMA 22 0.0003
322 RESPIRATORY TRACT INFECTION 4 0.0003
323 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0003
324 BLOOD GLUCOSE ABNORMAL 3 0.0002
325 TIC 1 0.0002
326 INJECTION SITE WARMTH 4 0.0002
327 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
328 INJECTION SITE DISCOLOURATION 2 0.0002
329 SKIN SWELLING 1 0.0002
330 SICKLE CELL ANAEMIA WITH CRISIS 1 0.0002
331 DRUG DOSE OMISSION 40 0.0002
332 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0002
333 SUDDEN DEATH 2 0.0002
334 INJECTION SITE BRUISING 12 0.0002
335 ENERGY INCREASED 1 0.0002
336 ENCEPHALITIS 1 0.0002
337 DIPLOPIA 4 0.0002
338 UNRESPONSIVE TO STIMULI 4 0.0002
339 HAEMODYNAMIC INSTABILITY 1 0.0002
340 LEFT VENTRICULAR DYSFUNCTION 1 0.0002
341 HAND FRACTURE 1 0.0002
342 INJECTION SITE RASH 4 0.0002
343 SINUS CONGESTION 2 0.0002
344 SKIN REACTION 2 0.0002
345 FEEDING DISORDER 2 0.0002
346 ARTHROPOD BITE 1 0.0002
347 EYE MOVEMENT DISORDER 1 0.0002
348 EOSINOPHIL COUNT INCREASED 1 0.0002
349 FACIAL PARALYSIS 1 0.0002
350 HYPOALBUMINAEMIA 1 0.0002
351 EYE SWELLING 5 0.0002
352 CONCUSSION 1 0.0002
353 RESPIRATORY DISTRESS 4 0.0002
354 SPINAL OPERATION 1 0.0002
355 OFF LABEL USE 76 0.0002
356 HYPERGLYCAEMIA 5 0.0002
357 PSEUDOMONAS INFECTION 1 0.0002
358 HAEMATOCRIT DECREASED 3 0.0002
359 UPPER RESPIRATORY TRACT INFECTION 6 0.0002
360 INJECTION SITE PAIN 35 0.0002
361 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 14 0.0002
362 CARDIAC OPERATION 1 0.0002
363 PSYCHIATRIC SYMPTOM 1 0.0002
364 STOMACH DISCOMFORT 1 0.0002
365 GRAFT VERSUS HOST DISEASE 1 0.0002
366 TENDON PAIN 1 0.0002
367 SHOCK HAEMORRHAGIC 1 0.0002
368 LEUKAEMIA 1 0.0002
369 PRODUCT DOSE OMISSION 13 0.0002
370 CARDIOMYOPATHY 2 0.0002
371 MYOCARDITIS 1 0.0002
372 HYPOPHAGIA 3 0.0002
373 AGGRESSION 7 0.0002
374 RHINORRHOEA 7 0.0002
375 INJECTION SITE DISCOMFORT 1 0.0002
376 DEAFNESS 3 0.0002
377 SWELLING FACE 8 0.0002
378 ANGINA UNSTABLE 1 0.0002
379 APPENDICITIS 1 0.0002
380 PYELONEPHRITIS 1 0.0002
381 CYANOSIS 2 0.0002
382 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0002
383 MUSCLE STRAIN 1 0.0002
384 ACCIDENTAL OVERDOSE 4 0.0002
385 URTICARIA 18 0.0002
386 ANGIOEDEMA 5 0.0002
387 DECREASED ACTIVITY 1 0.0002
388 APNOEA 1 0.0002
389 NERVE COMPRESSION 1 0.0002
390 SUBSTANCE ABUSE 1 0.0002
391 LIGAMENT SPRAIN 1 0.0002
392 CONGENITAL ANOMALY 1 0.0002
393 MOOD SWINGS 4 0.0002
394 FACE OEDEMA 2 0.0002
395 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0002
396 FLANK PAIN 1 0.0002
397 PROCEDURAL COMPLICATION 1 0.0002
398 RESTLESS LEGS SYNDROME 2 0.0002
399 BLOOD IRON DECREASED 1 0.0002
400 TREATMENT NONCOMPLIANCE 5 0.0002
401 EYE INFECTION 1 0.0002
402 CONVULSION 9 0.0002
403 FOOT FRACTURE 2 0.0002
404 BRAIN INJURY 1 0.0002
405 HAEMOLYTIC ANAEMIA 1 0.0002
406 COELIAC DISEASE 1 0.0002
407 POOR QUALITY SLEEP 2 0.0002
408 SKIN INFECTION 1 0.0002
409 EYELID PTOSIS 1 0.0002
410 OPTIC NEURITIS 1 0.0002
411 ERYTHEMA MULTIFORME 1 0.0002
412 INJECTION SITE HAEMATOMA 2 0.0002
413 INJECTION SITE HAEMORRHAGE 7 0.0002
414 ABDOMINAL DISTENSION 10 0.0001
415 GASTRIC ULCER 2 0.0001
416 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
417 ASPIRATION 1 0.0001
418 JOINT RANGE OF MOTION DECREASED 1 0.0001
419 UPPER LIMB FRACTURE 2 0.0001
420 FRACTURE 2 0.0001
421 RETCHING 2 0.0001
422 EATING DISORDER 2 0.0001
423 DECREASED APPETITE 20 0.0001
424 IMMUNODEFICIENCY 1 0.0001
425 DRUG-INDUCED LIVER INJURY 2 0.0001
426 PERSONALITY CHANGE 1 0.0001
427 FEELING JITTERY 2 0.0001
428 ELECTROLYTE IMBALANCE 1 0.0001
429 ATELECTASIS 1 0.0001
430 PRURITUS GENERALISED 3 0.0001
431 HEADACHE 57 0.0001
432 MICTURITION URGENCY 1 0.0001
433 HEPATOMEGALY 1 0.0001
434 HAIR DISORDER 1 0.0001
435 OESOPHAGITIS 1 0.0001
436 DISEASE RECURRENCE 2 0.0001
437 SKIN DISCOLOURATION 4 0.0001
438 VAGINAL DISCHARGE 1 0.0001
439 HYPOACUSIS 3 0.0001
440 MUSCLE ATROPHY 1 0.0001
441 DENTAL CARIES 1 0.0001
442 VOMITING 39 0.0001
443 WRIST FRACTURE 1 0.0001
444 OVERDOSE 15 0.0001
445 ABNORMAL BEHAVIOUR 4 0.0001
446 EYE PRURITUS 2 0.0001
447 IMMUNE SYSTEM DISORDER 1 0.0001
448 INJECTION SITE NODULE 1 0.0001
449 LETHARGY 5 0.0001
450 DEPRESSED MOOD 4 0.0001
451 POST PROCEDURAL HAEMORRHAGE 1 0.0001
452 RASH GENERALISED 3 0.0001
453 HEPATITIS 2 0.0001
454 PHARYNGITIS 1 0.0001
455 GINGIVAL BLEEDING 1 0.0001
456 PYREXIA 26 0.0001
457 CONDITION AGGRAVATED 18 0.0001
458 MALIGNANT MELANOMA 1 0.0001
459 HYPERHIDROSIS 10 0.0001
460 INJURY ASSOCIATED WITH DEVICE 1 0.0001
461 GRAND MAL CONVULSION 1 0.0001
462 NEPHROLITHIASIS 3 0.0001
463 GYNAECOMASTIA 3 0.0001
464 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
465 LACERATION 1 0.0001
466 INJECTION SITE REACTION 5 0.0001
467 LYMPHOMA 1 0.0001
468 DISTURBANCE IN ATTENTION 4 0.0001
469 MASS 1 0.0001
470 INJECTION SITE EXTRAVASATION 1 0.0001
471 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
472 HAIR COLOUR CHANGES 1 0.0001
473 OBESITY 1 0.0001
474 CONSTIPATION 13 0.0001
475 BLOOD POTASSIUM DECREASED 2 0.0001
476 DRUG ADMINISTRATION ERROR 3 0.0001
477 EYE DISORDER 2 0.0001
478 ANKLE FRACTURE 1 0.0001
479 SOMNOLENCE 13 0.0001
480 HEPATIC FAILURE 2 0.0001
481 ABDOMINAL PAIN 14 0.0001
482 NEUTROPHIL COUNT DECREASED 2 0.0001
483 ORAL HERPES 1 0.0001
484 IRRITABILITY 4 0.0001
485 INTESTINAL OBSTRUCTION 2 0.0001
486 DEVICE RELATED INFECTION 1 0.0001
487 PULMONARY FIBROSIS 1 0.0001
488 IRRITABLE BOWEL SYNDROME 1 0.0001
489 DEHYDRATION 8 0.0001
490 HERNIA 1 0.0001
491 INCORRECT ROUTE OF DRUG ADMINISTRATION 3 0.0001
492 HYPERSENSITIVITY 10 0.0001
493 DERMATITIS 1 0.0001
494 SPEECH DISORDER 3 0.0001
495 NECK PAIN 3 0.0001
496 SEIZURE 5 0.0001
497 HAEMATURIA 2 0.0001
498 ATRIAL FIBRILLATION 5 0.0001
499 THERAPEUTIC RESPONSE DECREASED 3 0.0001
500 GLAUCOMA 1 0.0001
501 HEPATOTOXICITY 1 0.0001
502 SINUSITIS 5 0.0001
503 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0001
504 WOUND 1 0.0001
505 MOUTH ULCERATION 1 0.0001
506 INCORRECT PRODUCT STORAGE 1 0.0001
507 SNEEZING 1 0.0001
508 NERVOUSNESS 3 0.0001
509 BRONCHITIS 4 0.0001
510 INFLUENZA 5 0.0001
511 POST PROCEDURAL COMPLICATION 1 0.0001
512 BODY TEMPERATURE INCREASED 1 0.0001
513 LIVER DISORDER 2 0.0001
514 INTENTIONAL SELF-INJURY 1 0.0001
515 MIGRAINE 4 0.0001
516 TREMOR 8 0.0001
517 PERICARDIAL EFFUSION 1 0.0001
518 NEURALGIA 1 0.0001
519 MALAISE 21 0.0001
520 PNEUMONIA 14 0.0001
521 INTERSTITIAL LUNG DISEASE 2 0.0001
522 LOSS OF CONSCIOUSNESS 6 0.0001
523 SEPSIS 5 0.0001
524 MUSCULOSKELETAL PAIN 3 0.0001
525 PNEUMONITIS 1 0.0001
526 ENCEPHALOPATHY 1 0.0001
527 OEDEMA PERIPHERAL 6 0.0001
528 UNDERDOSE 3 0.0001
529 DIABETIC KETOACIDOSIS 1 0.0001
530 ANAPHYLACTIC REACTION 2 0.0001
531 PNEUMONIA ASPIRATION 1 0.0001
532 NASOPHARYNGITIS 7 0.0001
533 CHROMATURIA 1 0.0001
534 FATIGUE 29 0.0001
535 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0001
536 DEPRESSION 10 0.0001
537 BACK PAIN 9 0.0001
538 MULTI-ORGAN FAILURE 1 0.0001
539 PRODUCT USE ISSUE 6 0.0001
540 HAEMOGLOBIN DECREASED 4 0.0001
541 BONE MARROW FAILURE 1 0.0001
542 ABDOMINAL PAIN LOWER 1 0.0001
543 OEDEMA 2 0.0001
544 GASTRITIS 1 0.0001
545 PAIN IN EXTREMITY 11 0.0001
546 INTENTIONAL PRODUCT MISUSE 3 0.0001
547 SWELLING 3 0.0001
548 EPILEPSY 1 0.0001
549 COUGH 9 0.0001
550 LABORATORY TEST ABNORMAL 1 0.0001
551 HYPERSOMNIA 1 0.0001
552 ALOPECIA 7 0.0001
553 ASTHMA 3 0.0001
554 DRUG PRESCRIBING ERROR 1 0.0001
555 SKIN DISORDER 1 0.0001
556 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0001
557 ASCITES 1 0.0001
558 HEPATIC ENZYME INCREASED 2 0.0001
559 RESPIRATORY DISORDER 1 0.0001
560 BONE PAIN 2 0.0001
561 SLEEP DISORDER 2 0.0000
562 ARTHRALGIA 12 0.0000
563 FEELING HOT 2 0.0000
564 HEAD INJURY 1 0.0000
565 ADVERSE EVENT 3 0.0000
566 PSYCHOTIC DISORDER 1 0.0000
567 COLITIS 1 0.0000
568 EXPIRED PRODUCT ADMINISTERED 1 0.0000
569 ANXIETY 9 0.0000
570 FEAR 1 0.0000
571 HYPOXIA 1 0.0000
572 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
573 ABDOMINAL PAIN UPPER 6 0.0000
574 MOVEMENT DISORDER 1 0.0000
575 HOT FLUSH 2 0.0000
576 SWOLLEN TONGUE 1 0.0000
577 ADVERSE DRUG REACTION 2 0.0000
578 EMOTIONAL DISORDER 1 0.0000
579 TREATMENT FAILURE 2 0.0000
580 GASTROINTESTINAL DISORDER 2 0.0000
581 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
582 LYMPHADENOPATHY 1 0.0000
583 VISUAL IMPAIRMENT 3 0.0000
584 ILL-DEFINED DISORDER 1 0.0000
585 ABDOMINAL DISCOMFORT 4 0.0000
586 RESTLESSNESS 1 0.0000
587 DIZZINESS 13 0.0000
588 PRODUCT DOSE OMISSION ISSUE 1 0.0000
589 DYSURIA 1 0.0000
590 ANGER 1 0.0000
591 NAUSEA 20 0.0000
592 EPISTAXIS 2 0.0000
593 CARDIAC FAILURE 2 0.0000
594 OCULAR HYPERAEMIA 1 0.0000
595 ACNE 2 0.0000
596 DRUG INTOLERANCE 2 0.0000
597 PARAESTHESIA 4 0.0000
598 PRODUCTIVE COUGH 1 0.0000
599 BLOOD GLUCOSE INCREASED 5 0.0000
600 ERYTHEMA 5 0.0000
601 AGITATION 2 0.0000
602 MENTAL DISORDER 1 0.0000
603 INFLAMMATION 1 0.0000
604 DYSKINESIA 1 0.0000
605 FEELING ABNORMAL 6 0.0000
606 WEIGHT INCREASED 5 0.0000
607 ROAD TRAFFIC ACCIDENT 1 0.0000
608 RASH 9 0.0000
609 RHABDOMYOLYSIS 1 0.0000
610 WEIGHT DECREASED 6 0.0000
611 PRURITUS 7 0.0000
612 VISION BLURRED 3 0.0000
613 EYE IRRITATION 1 0.0000
614 MEMORY IMPAIRMENT 3 0.0000
615 DISCOMFORT 1 0.0000
616 LUNG DISORDER 1 0.0000
617 BLOOD CHOLESTEROL INCREASED 1 0.0000
618 ASTHENIA 8 0.0000
619 INFLUENZA LIKE ILLNESS 2 0.0000
620 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
621 TINNITUS 1 0.0000
622 EYE PAIN 1 0.0000
623 CARDIO-RESPIRATORY ARREST 1 0.0000
624 SUICIDAL IDEATION 2 0.0000
625 ANAEMIA 4 0.0000
626 LEUKOPENIA 1 0.0000
627 CHEST PAIN 4 0.0000
628 COMA 1 0.0000
629 RASH PRURITIC 1 0.0000
630 HYPOAESTHESIA 3 0.0000
631 INCORRECT DOSE ADMINISTERED 3 0.0000
632 FLUID RETENTION 1 0.0000
633 CELLULITIS 1 0.0000
634 URINARY TRACT INFECTION 3 0.0000
635 CATARACT 1 0.0000
636 THROMBOCYTOPENIA 2 0.0000
637 DIARRHOEA 11 0.0000
638 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
639 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
640 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
641 DYSPHONIA 1 0.0000
642 DYSPNOEA 10 0.0000
643 PANCREATITIS 1 0.0000
644 DRY SKIN 2 0.0000
645 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
646 FEBRILE NEUTROPENIA 1 0.0000
647 MUSCULAR WEAKNESS 2 0.0000
648 MEDICATION ERROR 1 0.0000
649 GAIT DISTURBANCE 3 0.0000
650 STRESS 1 0.0000
651 DRUG INEFFECTIVE 18 0.0000
652 DRUG HYPERSENSITIVITY 3 0.0000
653 ARTHRITIS 1 0.0000
654 RESPIRATORY FAILURE 1 0.0000
655 PAIN 7 0.0000
656 DYSGEUSIA 1 0.0000
657 DRUG ABUSE 1 0.0000
658 DRUG EFFECT DECREASED 1 0.0000
659 NEUROPATHY PERIPHERAL 1 0.0000
660 DRUG INTERACTION 2 0.0000
661 PRODUCT QUALITY ISSUE 2 0.0000
662 CONFUSIONAL STATE 2 0.0000
663 OROPHARYNGEAL PAIN 1 0.0000
664 TACHYCARDIA 1 0.0000
665 CARDIAC ARREST 1 0.0000
666 CONTUSION 1 0.0000
667 DYSPEPSIA 1 0.0000
668 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
669 CARDIAC DISORDER 1 0.0000
670 HEART RATE INCREASED 1 0.0000
671 DISEASE PROGRESSION 1 0.0000
672 PLATELET COUNT DECREASED 1 0.0000
673 SYNCOPE 1 0.0000
674 FALL 3 0.0000
675 PALPITATIONS 1 0.0000
676 HOSPITALISATION 1 0.0000
677 PERIPHERAL SWELLING 1 0.0000
678 BLOOD PRESSURE INCREASED 1 0.0000
679 RENAL FAILURE 1 0.0000
680 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
681 DEATH 5 0.0000
682 MYALGIA 1 0.0000
683 MUSCLE SPASMS 1 0.0000
684 HYPOTENSION 1 0.0000
685 INSOMNIA 1 0.0000